janssen_latest_logo_on_sign

Janssen closes plant in California, 49 positions axed

pharmafile | April 3, 2019 | News story | Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, Vacaville, california 

Janssen are letting go of 49 employees due to the closure of their plant in Vacaville, California.

The Johnson & Johnson subsidiary took over the plant in 2001, after the healthcare conglomerate acquired the Palo Alto-based ALZA Corporation for $10.5 billion.

However the permanent closure will see 49 workers lose their jobs, as Janssen announced their decision to close the Vacaville facility. The firm said that the plant was no longer needed due to a shift in focus towards other areas.

“As part of this transformation, we will scale down production at our Vacaville, California facility with the intent to fully exit the site by the end of 2022,” J&J spokesman Matthew Johnson said.

Louis Goss

Related Content

Johnson & Johnson to acquire Shockwave Medical

Johnson & Johnson (J&J) and Shockwave Medical have announced that they have entered into a …

FDA approves J&J’s Opsynvi for PAH treatment

Johnson & Johnson (J&J) has announced that the US Food and Drug Administration (FDA) has …

Johnson & Johnson acquires Ambrx Biopharma for approximately $2bn

Johnson & Johnson (J&J) has announced that it has successfully completed its acquisition of Ambrx …

Latest content